Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).
Wen PY; Yung WK; Lamborn KR; Norden AD; Cloughesy TF; Abrey LE; Fine HA; Chang SM; Robins HI; Fink K; Deangelis LM; Mehta M; Di Tomaso E; Drappatz J; Kesari S; Ligon KL; Aldape K; Jain RK; Stiles CD; Egorin MJ; Prados MD; Neuro-Oncology, 2009, vol. 11, issue 6, p 853, ISSN 15235866. ISBN 15235866.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef